Literature DB >> 26840285

A SILAC-Based Approach Elicits the Proteomic Responses to Vancomycin-Associated Nephrotoxicity in Human Proximal Tubule Epithelial HK-2 Cells.

Zhi-Ling Li1, Shu-Feng Zhou2.   

Abstract

Vancomycin, a widely used antibiotic, often induces nephrotoxicity, however, the molecular targets and underlying mechanisms of this side effect remain unclear. The present study aimed to examine molecular interactome and analyze the signaling pathways related to the vancomycin-induced nephrotoxicity in human proximal tubule epithelial HK-2 cells using the stable isotope labeling by amino acids in cell culture (SILAC) approach. The quantitative proteomic study revealed that there were at least 492 proteins interacting with vancomycin and there were 290 signaling pathways and cellular functions potentially regulated by vancomycin in HK-2 cells. These proteins and pathways played a critical role in the regulation of cell cycle, apoptosis, autophagy, EMT, and ROS generation. These findings suggest that vancomycin-induced proteomic responses in HK-2 cells involvefunctional proteins and pathways that regulate cell cycle, apoptosis, autophagy, and redox homeostasis. This is the first systemic study revealed the networks of signaling pathways and proteomic responses to vancomycin treatment in HK-2 cells, and the data may be used to discriminate the molecular and clinical subtypes and to identify new targets and biomarkers for vancomycin-induced nephrotoxic effect. Further studies are warranted to explore the potential of quantitative proteomic analysis in the identification of new targets and biomarkers for drug-induced renal toxicity.

Entities:  

Keywords:  SILAC; nephrotoxicity; proteomics; vancomycin

Mesh:

Substances:

Year:  2016        PMID: 26840285      PMCID: PMC6273696          DOI: 10.3390/molecules21020148

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  4 in total

1.  Vitamin C reduces vancomycin-related nephrotoxicity through the inhibition of oxidative stress, apoptosis, and inflammation in mice.

Authors:  Juan He; Wenyun Xu; Xiaoxiao Zheng; Bing Zhao; Tongtian Ni; Ping Yu; Siyu Deng; Xiaoxia Pan; Erzhen Chen; Enqiang Mao; Xiaolan Bian
Journal:  Ann Transl Med       Date:  2021-08

2.  A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells.

Authors:  Qiaohua Zhu; Meihua Luo; Chengyu Zhou; Zhiwei Zhou; Zhixu He; Xinfa Yu; Shufeng Zhou
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 3.  Mass Spectrometry in Advancement of Redox Precision Medicine.

Authors:  Xiaofei Chen; Jingyun Lee; Hanzhi Wu; Allen W Tsang; Cristina M Furdui
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 3.650

4.  Drug Design and Discovery: Principles and Applications.

Authors:  Shu-Feng Zhou; Wei-Zhu Zhong
Journal:  Molecules       Date:  2017-02-13       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.